Primary |
Schizophrenia |
26.9% |
Drug Use For Unknown Indication |
15.1% |
Product Used For Unknown Indication |
11.3% |
Psychotic Disorder |
9.5% |
Schizophrenia, Paranoid Type |
8.8% |
Hypertension |
5.1% |
Schizoaffective Disorder |
3.0% |
Agitation |
2.7% |
Bipolar I Disorder |
2.5% |
Hyperlipidaemia |
2.4% |
Bipolar Disorder |
1.9% |
Diabetes Mellitus |
1.9% |
Anxiety |
1.7% |
Delusional Disorder, Unspecified Type |
1.7% |
Tic |
1.4% |
Schizophrenia, Disorganised Type |
1.2% |
Hiv Infection |
0.8% |
Schizophrenia, Catatonic Type |
0.8% |
Prophylaxis |
0.7% |
Tourette's Disorder |
0.7% |
|
Weight Increased |
62.8% |
Tachycardia |
5.6% |
Toxicity To Various Agents |
2.8% |
Parkinsonism |
2.3% |
Pulmonary Embolism |
2.3% |
Tardive Dyskinesia |
2.3% |
Treatment Noncompliance |
2.3% |
Weight Decreased |
2.3% |
Psychotic Disorder |
1.9% |
Tremor |
1.9% |
Akathisia |
1.4% |
Drug Administration Error |
1.4% |
Mental Disorder |
1.4% |
Neuroleptic Malignant Syndrome |
1.4% |
Rhabdomyolysis |
1.4% |
Schizophrenia |
1.4% |
Suicide Attempt |
1.4% |
Ventricular Tachycardia |
1.4% |
Vomiting |
1.4% |
Cognitive Disorder |
0.9% |
|
Secondary |
Schizophrenia |
20.0% |
Drug Use For Unknown Indication |
18.5% |
Product Used For Unknown Indication |
17.3% |
Schizophrenia, Paranoid Type |
6.5% |
Psychotic Disorder |
5.5% |
Bipolar I Disorder |
5.0% |
Schizoaffective Disorder |
4.1% |
Hypertension |
3.8% |
Agitation |
3.1% |
Aggression |
1.9% |
Bipolar Disorder |
1.9% |
Anxiety |
1.7% |
Confusional State |
1.4% |
Depression |
1.4% |
Enzyme Induction |
1.4% |
Panic Disorder |
1.4% |
Prophylaxis |
1.4% |
Diabetes Mellitus |
1.2% |
Schizophrenia, Catatonic Type |
1.2% |
Learning Disorder |
1.0% |
|
Tachycardia |
18.2% |
Hyperprolactinaemia |
11.4% |
Weight Increased |
9.1% |
Eyelid Ptosis |
6.8% |
Neuroleptic Malignant Syndrome |
6.8% |
Schizophrenia, Paranoid Type |
5.7% |
Hypotension |
4.5% |
Incorrect Dose Administered |
4.5% |
Pulmonary Embolism |
3.4% |
Septic Shock |
3.4% |
Tremor |
3.4% |
Urinary Retention |
3.4% |
Ventricular Tachycardia |
3.4% |
Completed Suicide |
2.3% |
Diarrhoea Haemorrhagic |
2.3% |
Embolism Arterial |
2.3% |
Gastric Cancer |
2.3% |
Injection Site Abscess |
2.3% |
Injection Site Pain |
2.3% |
Medication Error |
2.3% |
|
Concomitant |
Drug Use For Unknown Indication |
27.4% |
Schizophrenia |
17.0% |
Schizoaffective Disorder |
5.9% |
Hypertension |
5.6% |
Psychotic Disorder |
5.2% |
Bipolar I Disorder |
4.2% |
Schizophrenia, Paranoid Type |
3.8% |
Bipolar Disorder |
3.5% |
Non-hodgkin's Lymphoma |
3.5% |
Delusion |
3.1% |
Depression |
3.1% |
Product Used For Unknown Indication |
3.1% |
Breast Cancer Metastatic |
2.8% |
Insomnia |
2.1% |
Pain |
2.1% |
Drug Therapy |
1.7% |
Schizoaffective Disorder Bipolar Type |
1.7% |
Dementia Alzheimer's Type |
1.4% |
Parkinsonism |
1.4% |
Rheumatoid Arthritis |
1.4% |
|
Death |
10.0% |
Wrong Technique In Drug Usage Process |
8.6% |
Basedow's Disease |
7.1% |
Macular Oedema |
5.7% |
Overdose |
5.7% |
Type 2 Diabetes Mellitus |
5.7% |
Unresponsive To Stimuli |
5.7% |
White Blood Cell Count Decreased |
5.7% |
Pulmonary Embolism |
4.3% |
Restlessness |
4.3% |
Schizoaffective Disorder |
4.3% |
Sedation |
4.3% |
Suicide Attempt |
4.3% |
Treatment Noncompliance |
4.3% |
Weight Increased |
4.3% |
White Blood Cell Count Increased |
4.3% |
Akathisia |
2.9% |
Asthenia |
2.9% |
Camptocormia |
2.9% |
Completed Suicide |
2.9% |
|